A detailed history of Spotlight Asset Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Spotlight Asset Group, Inc. holds 5,641 shares of ABBV stock, worth $968,728. This represents 0.69% of its overall portfolio holdings.

Number of Shares
5,641
Previous 5,641 -0.0%
Holding current value
$968,728
Previous $1.03 Million 5.84%
% of portfolio
0.69%
Previous 0.76%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 18, 2022

BUY
$134.21 - $153.93 $6,576 - $7,542
49 Added 0.88%
5,641 $757,000
Q3 2021

Oct 28, 2021

SELL
$106.4 - $120.78 $20,428 - $23,189
-192 Reduced 3.32%
5,592 $603,000
Q1 2021

Apr 07, 2021

BUY
$102.3 - $112.62 $16,163 - $17,793
158 Added 2.81%
5,784 $626,000
Q4 2020

Feb 08, 2021

SELL
$80.49 - $108.67 $56,343 - $76,069
-700 Reduced 11.07%
5,626 $603,000
Q3 2020

Oct 30, 2020

BUY
$85.91 - $100.83 $21,992 - $25,812
256 Added 4.22%
6,326 $554,000
Q2 2020

Jul 23, 2020

BUY
$73.37 - $98.18 $74,764 - $100,045
1,019 Added 20.17%
6,070 $596,000
Q4 2019

Apr 13, 2020

BUY
$72.13 - $90.25 $364,328 - $455,852
5,051 New
5,051 $403,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Spotlight Asset Group, Inc. Portfolio

Follow Spotlight Asset Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spotlight Asset Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Spotlight Asset Group, Inc. with notifications on news.